BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European stocks slipped into the red on Thursday as investors awaited the outcome of a European Central Bank meeting later in the day for clues on the pace
Genome sequencing group Illumina on Tuesday (March 15), launched a cancer test in Europe that checks for a wide range of tumour genes in one tissue sample, potentially helping patients with rare diseases to be matched up with treatment options. The test, which Illumina says scans for more mutations than any available kits, comes amid drug industry efforts to develop.
By Ludwig Burger (Reuters) - Genome sequencing group Illumina on Tuesday launched a cancer test in Europe that checks for a wide range of tumour genes.